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Background: Many people with intellectual disability present with challenging behaviour which often has serious
consequences such as the prescription of long term medication, in-patient admissions and disruption of normal
daily activities. Small scale studies of Positive Behaviour Support (PBS) delivered by paid carers suggest that it
reduces challenging behaviour and costs of care and improves quality of life. This study aims to investigate whether
professionals training in the delivery of PBS as part of routine practice is clinically and cost effective compared to
treatment as usual in community intellectual disability services.
Method: The study is a multi-centre cluster randomised controlled trial involving community intellectual disability
services in England and service users with mild to severe intellectual disability and challenging behaviour. The
teams will be randomly allocated into one of two conditions, either training and support to deliver PBS or treatment as
usual. We will carry out assessments of challenging behaviour, use of services, quality of life, mental health, and family
and paid carer burden at six and 12 months. We will monitor treatment fidelity and we will interview a sample of paid
and family carers, service users, staff and managers about what they think of the treatment and how best we can
deliver it in routine care. The main outcome is reduction in challenging behaviour at one year after randomisation.
We will also carry out a health economic evaluation to examine the costs and consequences of staff training in PBS.
Discussion: The study findings will have significant implications for the delivery of PBS in community based services
with the potential for reducing inpatient admissions and out-of-area placements for adults with intellectual disability
and challenging behaviour.
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Intellectual disability is a disorder that includes impair-
ments in three domains, i.e. cognitive ability, social skills
and adaptive abilities and it should be evident during de-
velopment [1]. There are estimated to be 800,000 people
with mild and 112,000 people with severe intellectual
disability in the UK [2]. Challenging behaviours are com-
mon in this population with a point prevalence in adults
of 22.5% and a two year incidence of 4.6% [3]. Aggression
is by far the commonest type of challenging behaviour
with a reported prevalence of 11% to 27% [4]. Challenging
behaviour is associated with increase in receipt of anti-
psychotic medication, service use, hospitalisation, restrict-
ive care practices and deprivation [5-8]
Reduction of challenging behaviour has been the focus
of many interventional approaches over the years. Most
of the literature comprises small-n and single case em-
pirical research delivering a variety of pharmacological
and psychosocial treatments [9-12]. However, there are
few well conducted RCTs and the findings of those that
have been carried out are inconclusive; most notably, a
trial of antipsychotics showed that they were no more ef-
fective than placebo [13] in reducing challenging behav-
iour. Overall, existing RCTs are small, subject to bias, have
only examined short-term outcomes and lack a cost effect-
iveness component or reports on health related quality of
life. A pilot RCT (n = 63) showed that Applied Behaviour
Analysis (ABA) delivered by a specialist team can signifi-
cantly improve irritability, lethargy and hyperactivity
and may be cost neutral over six months [11]. Further-
more, a naturalistic follow-up for two years after ran-
domisation showed a sustained positive effect of the
intervention on challenging behaviour [12]. An additional
qualitative exploration of the opinions of those involved
in the trial (patients, carers and staff) revealed that there
was strong support for clinical trials as a method of evalu-
ating psychological therapies to treat challenging behav-
iour [14].
The financial burden of challenging behaviour
European data on the cost of disorders of the brain [15]
estimate that the cost of intellectual disabilities is 43bn
euros most of which is accounted for by costs of direct
health and non-medical care. A survey of five London
areas showed that 67% (£14 million, 2004–2005 prices)
of combined medical and social care budgets supported
134 out-of-area placements for adults with intellectual
disability and challenging behaviour [16]. Individual care
packages commonly ranged from £100 k to 450 k per
annum. Other studies indicate that costs are higher for
people with more severe intellectual disability and those
with greater levels of challenging behaviour, with special-
ist accommodation accounting for the majority of the
cost [17-19].The origins of PBS
Positive Behaviour Support (PBS) and its precursor ABA
are multicomponent methods that purport to support
people with intellectual disability and challenging behav-
iour [20,21]. PBS more specifically has developed into a
discipline that focuses on the influence of the environ-
ment on behaviour rather than solely on the internal
drivers of the behaviours [22]. PBS based practice consists
of a flexible, multicomponent intervention which takes a
lifespan perspective, emphasises prevention and fosters
stakeholder participation. PBS practice includes a func-
tional assessment of the possible relationships between
specific environmental events and the target behaviours.
By identifying what reinforces the behaviour, practitioners
can put in place interventions which are designed to foster
prosocial actions. The final aim is to enhance the person’s
quality of life and his/her integration within the local
community. An important tenet of PBS is that challen-
ging behaviour is shaped by personal and psychological
experiences and helps the person, with often severe intel-
lectual disability, to exert some control over his/her envir-
onment. The challenging behaviour may be a response to
environmental cues or “schedule-induced”, that is, present
as a result of interactions between the individual and the
environment. These concepts have influenced the defin-
ition of challenging behaviour as “behaviour of such inten-
sity, frequency or duration that the physical safety of the
person or others is placed in serious jeopardy or behaviour
which is likely to seriously limit or deny access to the use of
ordinary community facilities” [23].
PBS is a widely applied complex intervention to a num-
ber of conditions such as autism spectrum disorders, in
education, mental health and other fields in health and so-
cial care.
PBS based staff training
Specific staff competencies are a crucial factor in main-
taining improvements in behaviour. However, given the
resource associated with delivering PBS, only about half of
service users in need of PBS may be treated at any time
[24]. Lack of competencies in managing challenging be-
haviour is also an important factor in perpetuating out-of-
area placements [25,26]. Even where there are tertiary
specialist teams which provide ABA/PBS, service users
often have to wait several months to receive help.
One approach to meeting this shortfall is to train paid
carers and professional staff in PBS. McClean et al. [24]
and Grey & McClean [27] have reported descriptive data
on training 132 paid carers in a non randomised clinical
study (n = 60) that reported significant reductions in chal-
lenging behaviour in people in the target group compared
with controls. However, the instrument used to measure
the primary outcome does not have established psycho-
metric properties, the study was uncontrolled and included
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likely to require a different set of skills and knowledge from
the outset. The authors estimated that PBS based training
may lead to savings of £2 K per person treated.
The central objective of good practice in treating chal-
lenging behaviour is maintain individuals who present
with such behaviours locally and to avoid transfers to out-
of-area facilities [28]. Other guidance advocates a person
centred approach encompassing tenets of PBS which leads
to environments capable to deal with such behaviour and
the implementation of skilled commissioning for care
provision [29].
We argue that a rigorous evaluation of the clinical and
cost effectiveness of PBS delivered by appropriately trained
staff is long overdue. The focus of this project is highly rele-
vant given the widespread implementation of PBS and thus
the findings would have significant practice and policy ben-
efits internationally. Moreover, the economic analysis will
determine whether the intervention incurs costs beyond
and above treatment as usual and any reductions in chal-
lenging behaviour are associated with reduced use or re-
sources and improved quality of life.
Primary objective
To compare changes in carer reported ratings of challen-
ging behaviour at 12 months in adults with intellectual
disability who are treated in teams trained to deliver PBS
in addition to TAU with those treated in teams that deliver
TAU alone.
Secondary objectives
i. To compare the costs of care in each arm.
ii. To examine the impact of the intervention and TAU
at 12 months on prescription of psychotropic
medication, burden on family and paid carers,
service user mental status, and participation in
community-based activities compared to TAU alone.
iii. To carry out an exploratory analysis of the impact of
the intervention and TAU alone at 12 months on all
measures in a sub-sample of participants with autism
spectrum disorders (ASD).
iv. To measure the influence on the primary outcome
of level of intellectual disability, mental status and
ASD status and adaptive behaviour scores.
Methods
Trial design
Multicentre cluster researcher-masked randomised controlled
trial of manualised PBS-based staff training programme
for managing challenging behaviour in adults with intel-
lectual disability. The control group will receive treat-
ment as usual. Treatment as usual will also be available
to the participants in the intervention arm. The unit ofrandomisation will be the community intellectual disability
service. A cluster randomised design is considered appro-
priate in the light of this being an educational intervention
aimed at groups of professionals and the service [30].
Sample size
The primary outcome is the total Aberrant Behaviour
Checklist (ABC) score measured repeatedly at six and
12 months following recruitment. The pilot study [15]
generated mean baseline ABC scores of 45.4 (SD 26.4).
A reduction of 0.45 of a standard deviation on the ABC
score in the ABC group compared to the TAU group is
considered to be clinically important. Using an analysis of
covariance approach based on a correlation of 0.48 be-
tween the baseline and post-intervention ABC measure-
ments (as per pilot study, 15) 80 patients per arm will be
required to detect a difference of 0.45 SD with 90% power
and 5% significance level. Inflating for clustering within
the community intellectual disability services, using the
formula proposed by Eldridge et al. [31] which accounts
for variable cluster sizes and an intracluster correlation of
0.062 (estimated from the pilot study), an average cluster
size of 12 (we expect it to be 13, however, allowing for
10% attrition and rounding it up to the nearest integer we
have used a cluster size of 12 in our calculations), and a
standard deviation for the cluster size of 3, a total of 276
patients will be required. However, this sample size can be
reduced as each patient will provide two measurements of
ABC score. Using a correlation of 0.6 between the 6 and
12 months post intervention ABC measurements (15,16)
and a cluster size of 2, a total of 442 ABC measurements
from 221 patients will be required. In performing this cal-
culation we have assumed that there will be no treatment
by time period interaction over 12 months supported by
the pilot studies [11,12]. To allow for 10% attrition over
the 12 month period a total of 246 patients will be re-
cruited to the trial thus requiring 19 clusters. The sample
size calculation is based on the program and formulae in
STATA version 12.
Service and participant recruitment
Community intellectual disability services will be recruited
across several regions in England which cover urban,
semi-rural and rural areas.
We will ask two professionals from psychology, nursing,
occupational therapy or speech and language therapy in
each of the teams to volunteer to receive PBS training. A
further one or two professionals who express interest will
be on a waiting list in case of staff changes or drop outs.
Each trained professional will have a maximum caseload
of eight individuals at any time during the trial, i.e. a max-
imum of 16 service users per team. They may continue to
provide generic input for other service users such as tak-
ing part in dysphagia assessments, assessment of capacity
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ever, as they will be delivering an intensive intervention,
their generic workloads will need to be reduced. We an-
ticipate that delivery of the intervention will be about 30%
of their time. Once training has been completed, we an-
ticipate that 12–14 service users across sites per month
will be taken on for treatment.
Randomisation
Once the services have been recruited, randomisation will
be performed using a web based randomization system
which uses random permuted blocks on 1:1 allocation. Al-
though originally we had discounted minimisation given
the lack of good evidence for the impact of various vari-
ables on patient outcomes, given the variation in cluster
sizes we will use the following data in our randomisation
planning: team size (number of full time equivalent staff ),
in or out of London, number of service users registered
per team. We have calculated the ratio of staff:patient in
and out of London teams and in order to account for the
variation we will stratify the teams by a binary factor to in-
dicate whether a team is below or above a median ratio.
Randomisation will take place after the participants have
been screened for eligibility and consented to the trial.
Baseline data collection will follow.
Masking
Research assistants but not teams will be blind to group
allocation of the service. They will be asked to retain a
diary of their estimation of which treatment the partici-
pant is allocated to and to report occasions where this
has been disclosed to them in the course of their work.
Unmasking will not occur until after the study endpoint
and once the database is locked. Finally we will compare
guesses about participant allocation between trial arms
in order to determine any loss of blinding and potential
bias and we will adjust for any bias detected.
Possible sources of bias
One potential source of bias is transfer of trained staff
between trained and control teams during the trials. We
have examined the turnover of health staff in a number
of services which have expressed interest in participating
and this is well below 13% which is considered very low
based on National Health Service performance data. Fur-
thermore contamination between study arms is unlikely
given the more intensive nature of the intervention.
However, PBS principles are being taught widely there-
fore, some knowledge of PBS will be unavoidable. We
will collect information from all participating teams on
the level of knowledge and training the staff may have
had in delivering any aspects of PBS. Another potential
source of bias may derive from variation in patient char-
acteristics between teams. However, we do not anticipatesubstantial variation in this respect as the teams will
cover diverse geographical areas thus reducing the possi-
bility of bias.
Selection bias resulting from recruiting participants
after cluster allocation has been revealed will be avoided
by completing recruitment and screening assessment
prior to randomisation.
Inclusion criteria
a) Service users: Eligible to receive care from
intellectual disability services; mild to severe
intellectual disability; aged 18 years and over; total
ABC score of at least 15 (indicates a degree of
challenging behaviour occurring at least weekly
including verbal or physical aggression,
hyperactivity, refusal to attend activities, non
responsiveness that requires professional input).
b) Service: Willing to participate; availability of at least
two staff members willing to train; written
agreement by the service manager to participate.
Exclusion criteria
a) Service users: primary clinical diagnosis of personality
disorder or substance misuse; relapse in pre-existing
mental disorder; decision by clinical team that a
referral to the study would be inappropriate,
e.g. there is an open complaint investigation.
b) Service: there are no team members willing to train;
the service has already received and implements PBS
for their service users.
Interventions
PBS based staff training (in addition to treatment as usual)
The training, which will be supported by a treatment man-
ual will comprise the following sections:
a) Functional Behavioural Assessment and formulation
skills
 Brief Behavioural Assessment Tool for brief
functional analyses
b) Primary Prevention
c) Secondary Prevention and Reactive Strategies
d) Periodic Service Review and Problem Solving
 Developing individualised periodic service reviews
 Trouble shooting
The training will take place on six days spread over
15 weeks. Section (a) will be delivered over a two day
workshop and sections (b) to (d) over another two day
workshop six weeks later. Participating proflessionals are
expected to begin undertaking functional assessments
of service users’ between the two workshops. The final
Hassiotis et al. BMC Psychiatry 2014, 14:219 Page 5 of 10
http://www.biomedcentral.com/1471-244X/14/219two-day workshop eight weeks later will include discus-
sion on how to effectively implement behavioural plans
and provide problem solving strategies.
Post-workshop mentoring arrangements have been
arranged.
While mentors will take all practical steps to ensure
appropriate contacts are put in place, responsibility for
making best use of supervision rests with participants.
Throughout the training and mentoring, participants will
be reminded that the present training model is aimed at
intervention for individuals who do not show the most
complex challenging behaviours; intervention for such indi-
viduals will require more intensive and skilled intervention.
Clinical responsibility for each case and for responding to
any emergencies remains with the local services. When a
service user presents in a clinical emergency, the clinical
team will manage the emergency following which the treat-
ment will be resumed as appropriate.
At the end of treatment, the service users and their
paid or family carers will receive a report-in accessible
format for the service users- that describes the main
gains from treatment and strategies to use if problems
arise again.
One day training seminar on PBS will be offered to the
teams allocated to the control arm at the end of the
study.
Treatment as usual (TAU)
Most community intellectual disability services provide
a range of health interventions that include but are not
limited to psychiatric assessment and management, nurs-
ing support, psychology, speech and language therapy, oc-
cupational therapy and counselling. There may be some
variation in resources but service users with challenging
behaviour are likely to receive a range of broadly defined
behavioural, psychosocial and pharmacological interven-
tions. The latter may be influenced by or broadly based on
treatment guidelines published by the British Psycho-
logical Society and the Royal College of Psychiatrists [32].
Frequency and duration of follow up
All participants will be followed up at six and 12 months
after randomisation. The flow of the study can be seen
in Figure 1.
Ethical issues, research governance and consent
The study has received ethical approval by the NRES
Committee London - Harrow (reference 12/LO/1378).
All materials relevant to the study were made into easy
read with the assistance of the service users reference
group. Research and Development permissions have also
been obtained for the participating teams. Details can be
found in the Additional file 1: Table S1.Written consent to contact patients and collect data for
the purpose of the study will be obtained from the service
users where possible, and family and paid carers. We will
identify a consultee where one is available, or nominate
one for those service users who lack capacity as per Men-
tal Capacity Act 2005 [33]. Our previous work suggests
that PBS is well received, of potential benefit and does no
harm. As with any trial which includes TAU, participants
may have a preference for the active treatment. However,
it remains to be determined whether training staff in PBS
is effective. Where continued participation would be in-
appropriate, e.g. admission to hospital under detention of
the MHA 1983, participants will be withdrawn from the
study. The service user’s General Practitioner will be noti-
fied of the service user’s participation in the trial. All the
research team members will follow the required risk as-
sessment procedures including guidelines for risk manage-
ment and safeguarding processes.
Outcome measures and instruments
Quantitative assessments
We will collect data on demographic characteristics (gen-
der, age, ethnicity), level of intellectual disability and adap-
tive behaviour at baseline. The latter two will be assessed
by the Wechsler Abbreviated Scale of Intelligence (WASI)
[34] and the short version of the Adaptive Behaviour Scale
[35] respectively. Cause of learning disability will be re-
corded if known.
Primary outcome measure
Changes in challenging behaviour as measured by the
Aberrant Behaviour Checklist [36,37] over 12 months.
The instrument has been widely used for monitoring
changes in behaviour in people with intellectual disability
following treatment and has demonstrated acceptable reli-
ability and validity. The ABC scores can be separated into
five different factors comprising (I) Irritability, Agitation,
Crying (15 items), (II) Lethargy, Social Withdrawal (16
items), (III) Stereotypic Behaviour (7 items), (IV) Hyper-
activity, Non-compliance (16 items), and (V) Inappropri-
ate Speech (4 items). Each domain is rated on a four point
scale (0–3). A total score can be obtained by adding up all
domain scores. It will be completed by the person’s paid
or family carer at all time points.
Secondary outcome measures
Mental health and autism spectrum disorders will be
assessed by the mini version of the Psychopathology As-
sessment Scale for Adults with Developmental Disability
(mini PASADD) [38]. It is administered by trained pro-
fessionals to family and/or paid carers and to the service
user where possible. The instrument comprises 86 psychi-
atric symptoms with threshold scores for the following psy-
chiatric disorders: Depressive Disorder, Anxiety Disorder,
Figure 1 Trial schema.
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sive disorder, Psychosis, Dementia or Unspecified Disorder
and a screen for pervasive developmental disorder. The
latter will be administered once at baseline.
EuroQol Youth (EQ-5D-Y) will be used to calculate
Quality Adjusted Life Years (QALYs) in line with accepted
guidance [39]. The EQ-5D-Y is a 5 domain (usual ac-
tivity, self-care, mobility, pain and anxiety/depression),
3 level (no problems, some problems and extreme prob-
lems) questionnaire. It will be administered at all time
points.Community participation will be assessed with the
Guernsey Community Participation and Leisure Activities
Scale (GCPLAS) [40]. It was developed to monitor the im-
pact of interventions on the service user’s daily living. It
contains six categories of activity that refer to 49 oper-
ationally defined contacts. The frequency of participation
over the previous six month period is rated on a five point
scale. It will be administered at all time points.
Family carer burden will be measured by the Uplift/
Burden Scale [41], a 23-item scale that has six uplift and
17 burden items. The scale has previously been used in
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points.
Family carer psychiatric morbidity will be measured by
the GHQ12 [42].
Paid carer burden will be measured by the Caregiving
Difficulty Scale-Intellectual Disability (CDS-ID) [43]. It
is adapted from an existing scale and measures subject-
ive burden. It will be administered at all time points.
Costs of care will be collected using a modified version
of Client Services Receipt Inventory (CSRI) for people
with intellectual disability [44]. It will be administered at
all time points for the preceding 6 months.
Use and/or change of all medications will be recorded
during the study period.Qualitative component
We will carry out audiotaped interviews of i) a purposive
sample of 15 staff that have undergone training in PBS
to explore their views on the training and challenges
they faced by taking part in the study; ii) all service man-
agers in order to explore their viewpoint in terms of the
impact of the training on the service and the practices
that may underpin service response to challenging be-
haviour; iii) up to 15 paid and 15 family carers for their
views and experiences of having been allocated to the
intervention arm; iv) up to 15 service users who have ex-
perienced the intervention. We will develop a semi-
structured interview schedule with the help of both paid
and family carers and service users. It will be applied
flexibly and may be modified in order to be responsive
to emergent themes. If the intervention is shown to be
effective, this data will inform the scaling up of the inter-
vention across community intellectual disability services
in the UK. If it is ineffective, the data may give some in-
dication of where and why it failed.Process evaluation
We will develop a checklist specifically for the study to
monitor treatment fidelity. It will ask professionals deliv-
ering the intervention to rate whether or not essential
tasks were carried out in sessions (adherence) on a yes/
no rating. It will also contain a section for comment and
to rate whether the treatment goals were achieved by
the final session. Furthermore, the list of topics for dis-
cussion in supervision sessions with trainers will be
available as a record of any issues arising during the
trial. Samples of behavioural plans will be checked by
the training team as well as an independent advisor to
ensure that the quality of the assessments is maintained
throughout the trial. Finally we will collect information
regarding the resource implication for delivering the
intervention in terms of staff time spent in training,
supervision or travelling.Statistical analysis
We shall follow CONSORT guidelines for the analysis
of cluster randomised trials and reporting of findings
(http://www.consort-statement.org/).
The baseline characteristics of the PBS and TAU groups
will be summarised using means, standard deviation and
proportions as appropriate. A three level regression model
adjusting for baseline ABC measurements, time period
and effects of clustering by services and accounting for re-
peated measures within subjects will be used for the pri-
mary analysis. Similar analyses will be conducted for the
secondary outcomes using appropriate regression models
depending on the type of outcome. Results from all sec-
ondary analyses will be presented as estimates with confi-
dence intervals and treated as exploratory. If we encounter
missing data, bias due to missing data will be investigated
initially by comparing the characteristics of the trial partici-
pants with complete follow-up measurements and those
who have incomplete follow-up or no outcome data, de-
scriptively. If differences are observed in the participants’
characteristics in the descriptive analysis, factors which are
likely to be associated with the outcome will be included in
a multilevel logistic regression analysis (with missing yes or
no as outcome) to identify predictors of missing data. If
predictors associated with both missing data and the out-
comes are found, these will be included in the multilevel
models examining the effects of intervention on the out-
comes [45]. A sensitivity analysis will also be carried out to
examine the effect of PBS on ABC score after adjusting for
area deprivation and the service staff to patient ratio if ap-
propriate. Multiple imputation may be used as part of the
sensitivity analysis accounting for the clustered nature of
the data if considered appropriate [46-48]. As part of the
sensitivity analysis we will also examine intervention by
time period interaction. All analyses will be carried out on
an intention to treat basis. A detailed statistical analysis
plan will be agreed by the Trial Steering Committee prior
to the analysis of unblinded data.
Health economic evaluation
Analyses will be conducted from a health services perspec-
tive and from a societal perspective. The cost-effectiveness
measure will be the incremental cost per QALY gained of
PBS versus treatment as usual. This will be calculated as
the mean cost difference between PBS and treatment as
usual divided by the mean QALY difference to give the in-
cremental cost-effectiveness ratio (ICER). This will allow
for resource allocation decisions across different health
services. However, as there is no evidence of the relation-
ship between challenging behaviour and QALYs, we will
also calculate the cost per point change in the primary
outcome measure, (ABC). Unit costs will be taken from
standard published sources such as the Office for National
Statistics and Personal Social Services Research Unit
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supervision and training. Additional information on hos-
pital admissions and out-of-area transfers will be collected
to ensure costings of the secondary care component for
both trial arms are robust. Predetermined values will be
used [49,50] to calculate the area under the curve using
time-weighted averages of utility scores collected at base-
line and each follow up point. As baseline utility scores
are not controlled for prior to randomisation, utility scores
may differ between trial arms at baseline. Thus, regression
analysis will be used to control for differences in baseline
utility scores. We will use non-parametric methods for
calculating confidence intervals around the ICER based on
bootstrapped estimates of the mean cost and QALY differ-
ences. The bootstrap replications will also be used to con-
struct a cost-effectiveness [51] acceptability curve, which
will show the probability that PBS is cost-effective com-
pared to standard care at 12 months for different values of
the willingness of the NHS to pay for an additional QALY.
We will also subject the results to extensive deterministic
(one-, two- and multi-way) sensitivity analyses.
Qualitative analysis
The audiotaped interviews will be transcribed by the
study administrator and the research assistants will im-
port the transcripts onto suitable software [52] that will
be used to manage the data. The thematic analysis of the
nested qualitative study will be guided by the framework
approach [53]. Codes will be assigned to segments of
interview data according to agreed labels. Once codes are
applied to interview data, the outcome will be checked
by another member of the research group to monitor
the face validity of the assigned cases and add further
codes. Higher level themes will be suggested in dis-
cussions with the research group. Furthermore, we will
perform further validation of the material by presenting
the participants with a summary of the findings in order
to establish that the account we have given is clear and ac-
ceptable to the respondents.
Patient and carer involvement
A patient reference group (Camden Advocacy) will support
the project and will assist with the research governance re-
quirements including input to easy read versions of trial
materials such as information and consent forms, piloting
of instruments and qualitative interview topic guides with
reference to people with intellectual disability and dissem-
ination. The Challenging Behaviour Foundation, an inde-
pendent charity of family carers of people with intellectual
disability and challenging behaviour were involved in the
development of the study and have taken on the role of
champions for recruitment, reviewing study related infor-
mation, the qualitative interviews topic guides and final
dissemination of the findings.Discussion
Large scale comparative evaluations of training in PBS
are lacking. It is anticipate that the trial findings will pro-
vide important information about its clinical and costs ef-
fectiveness as well as its delivery in ordinary practice. This
is of particular interest to both professionals and clinicians
as PBS has been embraced as the intervention of choice
for managing challenging behaviour by a wide spectrum
of stakeholders.
Additional file
Additional file 1: Table S1. R & D departments and corresponding
sites in the participating NHS Trusts.
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